The GSEA analysis revealed that AS-99 suppressed transcriptional programs driven by MLL fusion proteins and HOXA9. Treatment with AS-99 also inhibited proliferation and induced differentiation and apoptosis in MLL leukemia cells, but not in control cell lines without MLL1 translocation, excluding general toxicity. The gene discussed is HOXA9; the disease is leukemia.